A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, you may be faced with multiple treatment options and asked to make a ...
In this meta-analysis, researchers evaluated the use and/or prolongation of ADT in men with non-metastatic prostate cancer undergoing definitive radiotherapy.
Cancer patients who quit smoking had a two-year survival rate of about 85%, compared with 74% for those who kept smoking. Among patients with advan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback